A non-steroidal anti-inflammatory drug (ketoprofen) does not delay β-TCP bone graft healing

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 3310-3317

  Nyangoga, Herve ^a   Aguado, Eric ^a,b   Goyenvalle, Eric ^a,b   Baslé, Michel Felix ^a   Chappard, Daniel ^a  

^a INSERM   (France)

^b LUNAM UNIVERSITÉ   (France)

Author keywords

Bone graft; Bone healing; Microct; Non steroidal anti inflammatory drugs; TCP

Indexed keywords

BONE; GRANULATION; MACROPHAGES; SURGERY; TRANSMISSION CONTROL PROTOCOL;

BONE GRAFT; BONE HEALING; KETOPROFEN; MICRO CT; MICROBEADS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; ORAL AND MAXILLOFACIAL SURGERIES; POLYURETHANE FOAM; TRI-CALCIUM PHOSPHATES; Β-TCP;

COMPUTERIZED TOMOGRAPHY;

CALCIUM PHOSPHATE; KETOPROFEN; BETA-TRICALCIUM PHOSPHATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; BONE REMODELING; DRUG EFFECT; MACROPHAGE FUNCTION; MICRO-COMPUTED TOMOGRAPHY; NEW ZEALAND; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; ANIMAL; BONE TRANSPLANTATION; CYTOLOGY; FEMUR; FLUORESCENCE MICROSCOPY; RADIOGRAPHY; SCANNING ELECTRON MICROSCOPY; WOUND HEALING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; FEMUR; KETOPROFEN; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; RABBITS; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 77956644415     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.042     Document Type: Article

References (50)

1. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci: Mater Med 2003;14:195-200.
2. Driessen AA, Klein CP, de Groot K. Preparation and some properties of sintered beta-whitlockite. Biomaterials 1982;3:113-6.
3. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 1981:259-78.
4. Aunoble S, Clément D, Frayssinet P, Harmand MF, Le Huec JC. Biological performance of a new p-TCP/PLLA composite material for applications in spine surgery: In vitro and in vivo studies. J Biomed Mater Res A 2006;78:416-22.
5. ®) for bone regeneration in the reconstructive surgery of the jaws. Int J Oral Maxillofac Surg 2006;35:708-13.
6. Meyer C, Chatelain B, Benarroch M, Garnier JF, Ricbourg B, Camponovo T. Massive sinus-lift procedures with p-tricalcium phosphate: Long-term results. Rev Stomatol Chirur Maxillo-Fac 2009;110:69-75.
7. Bornstein MM, Chappuis V, Von Arx T, Buser D. Performance of dental implants after staged sinus floor elevation procedures: 5-year results of a prospective study in partially edentulous patients. Clin Oral Implants Res 2008;19:1034-43.
8. Daculsi G, Layrolle P. Osteoinductive properties of micro macroporous biphasic calcium phosphate bioceramics. Key Engen Mater 2004;254-256:1005-8.
9. Ogose A, Hotta T, Kawashima H, Kondo N, Gu W, Kamura T, et al. Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B 2005;72:94-101.
10. Chazono M, Tanaka T, Kitasato S, Kikuchi T, Marumo K. Electron microscopic study on bone formation and bioresorption after implantation of betatricalcium phosphate in rabbit models. J Orthop Sci 2008;13:550-5.
11. Fransen M. Preventing chronic ectopic bone-related pain and disability after hip replacement surgery with perioperative ibuprofen. A multicenter, randomized, double-blind, placebo-controlled trial (HIPAID). Control Clin Trials 2004;25:223-33.
12. Beck A, Krischak G, Sorg T, Augat P, Farker K, Merkel U, et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003;123:327-32.
13. Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Ogawa T, et al. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthopaedica 2005;76:470-4.
14. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. J Bone Joint Surg Br 2000;82:655-8.
15. Giordano V, Giordano M, Knackfuss IG, Apfel MIR, Gomes RDC. Effect of tenoxicam on fracture healing in rat tibiae. Injury 2003;34:85-94.
16. Pountos I, Georgouli T, Blokhuis TJ, Pape HC, Giannoudis PV. Pharmacological agents and impairment of fracture healing: What is the evidence? Injury 2008;39:384-94.
17. Dimmen S, Engebretsen L, Nordsletten L, Madsen JE. Negative effects of parecoxib and indomethacin on tendon healing: an experimental study in rats. Knee Surg Sports Traumatol Arthrosc 2009;17:835-9.
18. Horak D, Karpisek M, Turkova J, Benes M. Hydrazide-functionalized poly (2-hydroxyethyl methacrylate) microspheres for immobilization of horseradish peroxidase. Biotechnol Prog 1999;15:208-15.
19. Nyangoga H, Zecheru T, Filmon R, Baslé MF, Cincu C, Chappard D. Synthesis and use of pHEMA microbeads with human EA.hy 926 endothelial cells. J Biomed Mater Res B 2009;89:501-7.
20. Filmon R, Retailleau-Gaborit N, Brossard G, Grizon-Pascaretti F, Baslé MF, Chappard D. Preparation of β-TCP granular material by polyurethane foam technology. Image Anal Stereol 2009;28:1-10.
21. Schwartzwalder K, Somers H, Somers AV. Method of making porous ceramics. 1963, US Patent: 3 090 094.
22. Parfitt AM, Drezner MK, Glorieux FG, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595-610.
23. Chappard D. Technicalaspects:Howdowebestpreparebone samplesforproper histological analysis? In: Heymann D, editor. Bone cancer: progression and therapeutic approaches. London: Acad. Press. Elsevier Inc.; 2009. p. 203-10.
24. Zerbo IR, Bronckers AL, de Lange GL, van Beek GJ, Burger EH. Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases. Clin Oral Implants Res 2001;12:379-84.
25. Zijderveld SA, Zerbo IR, van den Bergh JP, Schulten EA, ten Bruggenkate CM. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int J Oral Maxillofac Implants 2005;20:432-40.
26. Knabe C, Koch C, Rack A, Stiller M. Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans. Biomaterials 2008;29:2249-58.
27. Galois L, Mainard D, Delagoutte JP. Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery. Int Orthop 2002;26:109-15.
28. Muschik M, Ludwig R, Halbhubner S, Bursche K, Stoll T. Beta-tricalcium phosphate as a bone substitute for dorsal spinal fusion in adolescent idiopathic scoliosis: preliminary results of a prospective clinical study. Eur Spine J 2001;10:S178-184.
29. Bouvard B, Legrand E, Audran M, Chappard D. Glucocorticoid-induced osteoporosis: a review. Clin Rev Bone Miner Metab 2010;8:15-26.
30. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-5.
31. Harder AT, An YH. The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: a concise review. J Clin Pharmacol 2003;43:807-15.
32. Seidenberg AB, An YH. Is there an inhibitory effect of COX-2 inhibitors on bone healing? Pharmacol Res 2004;50:151-6.
33. Bo J, Sudmann E, Marton PF. Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 1976;47:588-99.
34. Sudmann E, Bang G. Indomethacin-induced inhibition of haversian remodelling in rabbits. Acta Orthop Scand 1979;50:621-7.
35. Goodman SB, Ma T, Mitsunaga L, Miyanishi K, Genovese MC, Smith RL. Temporal effects of a COX-2-selective NSAID on bone ingrowth. J Biomed Mater Res A 2005;72:279-87.
36. Karachalios T, Boursinos L, Poultsides L, Khaldi L, Malizos KN. The effects of the short-term administration of low therapeutic doses of anti-COX-2 agents on the healing of fractures. An experimental study in rabbits. J Bone Joint Surg Br 2007;89:1253-60.
37. Boursinos LA, Karachalios T, Poultsides L, Malizos KN. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing? J Musculoskelet Neuronal Interact 2009;9:44-52.
38. Kondo N, Ogose A, Tokunaga K, Ito T, Arai K, Kudo N, et al. Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle. Biomaterials 2005;26:5600-8.
39. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 2004;109:2068-73.
40. Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger PM. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-9.
41. Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003;3:319-28.
42. Monthéard J, Kahovec J, Chappard D. Homopolymers and copolymers of 2-hydroxyethyl methacrylate for biomedical applications. In: Arshady R, editor. Desk reference of functional polymers; syntheses and applications. Washington DC: American Chemical Society; 1997. p. 699-717.
43. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006;11:812-8.
44. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-84.
45. Zecheru T, Filmon R, Rusen E, Marculescu B, Zerroukhi A, Cincu C, et al. Biomimetic potential of some methacrylate-based copolymers: a comparative study. Biopolymers 2009;91:966-73.
46. Mabilleau G, Moreau MF, Filmon R, Baslé MF, Chappard D. Biodegradability of poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophage cell line. Biomaterials 2004;25:5155-62.
47. Nagahara K, Isogai M, Shibata K, Meenaghan MA. Osteogenesis of hydroxyapatite and tricalcium phosphate used as a bone substitute. Int J Oral Maxillofac Implants 1992;7:72-9.
48. Eggli PS, Muller W, Schenk RK. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop Relat Res 1988;1:127-38.
49. Kim Y-H, Jyoti A, Byun I-S, Oh I-H, Min Y-K, Yang H-M, et al. Effects of macrophage on biodegradation of β-tricalcium phosphate bone graft substitute. J Kor Ceram Soc 2008;45:618-24.
50. Suzuki Y, Nishiyama T, Hasuda K, Fujishiro T, Niikura T, Hayashi S, et al. Effect of etidronate on COX-2 expression and PGE (2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles. J Orthop Sci 2007;12:568-77.